Trump's Tylenol Autism Claims Spark Outrage and Health Warnings

Recent claims by the Trump administration linking Tylenol to autism have ignited significant backlash from medical professionals and health officials. Critics argue that these statements are based on inconclusive research and could mislead pregnant women regarding medication safety. The controversy highlights ongoing concerns about misinformation in health policies and its potential impact on public health, particularly for vulnerable populations.